back to ramping again..
there are no studies underway for either of those indications that will result in a partnership.
if any pharma wanted acro they'd have done a deal by now. It's been how many years?
ms is years away.
any partnership is years away.
dxb always had the phase 3 trial lined up. Dkd was the cream on the top and it the trial didn't go well, fsgs was always the main game. Very different to per.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $5.737K | 573.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3633138 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 3174000 | 4 |
View Market Depth
| Last trade - 15.22pm 17/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |